Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-041730
Filing Date
2021-08-12
Accepted
2021-08-11 17:42:07
Documents
90
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_abvcbiopharma.htm   iXBRL 10-Q 1248646
2 CERTIFICATION f10q0621ex31-1_abvcbio.htm EX-31.1 10994
3 CERTIFICATION f10q0621ex31-2_abvcbio.htm EX-31.2 11076
4 CERTIFICATION f10q0621ex32-1_abvcbio.htm EX-32.1 4822
5 CERTIFICATION f10q0621ex32-2_abvcbio.htm EX-32.2 5128
  Complete submission text file 0001213900-21-041730.txt   7355748

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20210630.xsd EX-101.SCH 93388
7 XBRL CALCULATION FILE abvc-20210630_cal.xml EX-101.CAL 42954
8 XBRL DEFINITION FILE abvc-20210630_def.xml EX-101.DEF 362604
9 XBRL LABEL FILE abvc-20210630_lab.xml EX-101.LAB 664061
10 XBRL PRESENTATION FILE abvc-20210630_pre.xml EX-101.PRE 376498
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_abvcbiopharma_htm.xml XML 916143
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 211164804
SIC: 2834 Pharmaceutical Preparations